LifeArc Ventures

Later this month, our CEO, Hakim Yadi Ph.D. OBE, will be in Berlin, Germany, for Frontiers Health. Catch Hakim in the plenary fireside chat with Marc Slujis and David Klein: "Back to the future…. fully integrated, truly personalized drug-digital treatments - When will we get there?" 🗓️ 18 October | 🕐 10:20 AM CET Set in the heart of the city, the event will gather hundreds of professionals and experts to discuss the digital evolution in health and care. For more details and to get your pass, visit: https://lnkd.in/dNN4MMd To arrange a meeting, visit: https://lnkd.in/efQzV5rB #FH24 #TechBio #DigitalHealth #HealthEquity

☕ The amount of milk in your morning coffee.  🎵 The playlist for your evening commute. 🍳The way you enjoy your eggs for breakfast.   Many things in modern life are tailored precisely to our individual needs and preferences. So it’s hard to believe that medication isn’t.   Closed Loop Medicine is here to change that.   Our technology leverages AI and machine learning to calculate the precise doses that are right for each and every one of us.   Helping us live better – and steer clear of those unnecessary side effects.   We’re on a mission to change the way healthcare is delivered, one milligram at a time.   💡 Because if anything should be tailor-made, surely it should be medicine?

BioIndustry Association (BIA)’s TechBio UK is back in London next Wednesday, bringing together companies working at the intersection of biotechnology and technology to drive innovation in drug discovery and tackle broader R&D challenges in bio-, agri-, and industrial technologies. Join our CEO Hakim Yadi Ph.D. OBE for a panel on lessons learned and the future of the TechBio landscape: “Question Time: The State of TechBio in the UK” 🗓️ 16 October | 🕐 11:15 AM – 12:15 PM BST To register and secure your spot, visit: https://lnkd.in/eRB4eJBH #TechBio #Biotech #Innovation

We are excited to announce that our Chief Technology Officer, John McCafferty, will be speaking at the Festival of Biologics in Basel, Switzerland next week. Join John for his talk to learn about the recent advancements in targeting ion channels with #KnotBodies®. 📍16th October 2024 15.00-16.00 CET 📢 "Creating ion channel modulating antibodies by fusing cysteine-rich miniproteins into antibody CDR loops" #festivalofbiologics #festofbiologics #biologics #KnotBodies® #networking

Thrilled to share that Ozlo has been selected as a finalist for the 2024 Digiday Awards in the Best Product Launch Campaign category. 🏆 https://bit.ly/4dbth3r Kudos to our fellow nominees, honored to be in your company! 💜💤

"We saw its potential. When it was shut down, we acquired that IP, raised capital, reengineered the product, and relaunched it." -Rockwell Shah Tune in to the CEOdotcom's podcast to hear our fearless leader share his journey with Sleepbuds and the secrets behind getting them to market. 😴🎙️✨

If you believe in the important work we're doing at Ozlo, we need your help! 🙏 We’re in the running for the annual MedTech Innovator Best Video Competition. Watch our submission video here: https://lnkd.in/g3NYEC8M If you have a minute, all we ask is you WATCH, LIKE & SHARE this video with all of your friends & family. Every view & like counts! 👀 Your support means so much to all of us at Ozlo. 💜💤

We're Rising Star Quarterfinalists! 🎖️ https://bit.ly/4dQfY9S Ozlo is proud to announce we were selected from thousands of companies as a Quarterfinalist for The 2024 The Digital Health Hub Foundation - Digital Health Awards in the Rising Star - Consumer Wellness category! 🥳 The Digital Health Hub Foundation Awards honor outstanding health technologies and innovations dramatically transforming healthcare, and our team is honored to even be considered.

At 61, Gaynor Hardman was diagnosed with bronchiectasis, an overlooked and misunderstood chronic respiratory disease. With limited knowledge of this condition, it wasn't until Gaynor experienced severe breathlessness and was hospitalised that she received the right care and information to manage her condition. Unfortunately, this is often the case for people with bronchiectasis, who are left uncertain about how to manage their condition. As a result, they are frequently caught in a cycle of infection, with limited treatment options due to antibiotic resistance and a lack of effective therapies. Read Gaynor's story about her path to diagnosis and the challenges of learning to live with such a debilitating condition with no cure: https://t.ly/YQbuZ To improve the lives of people living with bronchiectasis, we must gain a better understanding of this disease and invest in developing new treatments and tools to either cure or help people better manage their respiratory health. Through our Chronic Respiratory Infection Translational Challenge, we are funding research and partnering with others in this space to accelerate the development of life-changing innovations.

🌍 A recent study in The Lancet Psychiatry revealed that 1 in 2 people worldwide will develop a mental health disorder during their lifetime. 🧠 With up to 46% of depression patients not fully responding to traditional antidepressants (National Institutes of Health), the need for new treatments is more critical than ever. This #WorldMentalHealthDay, Cumulus Neuroscience is proud to work with Delix Therapeutics, a company transforming brain health by developing treatments that are safe, fast-acting, and long-lasting. By targeting #neuroplasticity and bringing the first novel #neuroplastogen to the clinic, Delix is bringing much-needed hope to those facing difficult-to-treat #neuropsychiatric and neurological disorders. #WMHD2024 #CNS #DigitalBiomarkers #Innovation #MentalHealthMatters